ArticleJAACAP open2025
Impact of Social Determinants of Health and Professional Guidelines for Pharmacotherapy and Psychotherapy Recommendations for the Treatment of Young Children: A Retrospective Study.
Article in JAACAP open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Objective: To examine pharmacotherapy and psychotherapy treatment recommendations among different races and socioeconomic groups of young children. A secondary objective evaluated whether changes in the 2007 American Academy of Child and Adolescent Psychiatry (AACAP) guidelines for attention-deficit/hyperactivity disorder (ADHD) treatment affected community prescribing practices. Hypotheses were that non-White children would be less likely to have psychotherapeutic treatments recommended for mental health issues and children with lower socioeconomic status index scores would be less likely to receive a psychotropic medication prescription. Method: The sample included 1,764 children ages 7 years or younger prescribed at least 1 psychotropic medication for psychiatric indications between 2003 and 2019 identified through the Rochester Epidemiology Project. Data were examined with χ Results: The sample included 29% female, 1.6% Asian, 6.9% Black, 5.3% Hispanic, 7.7% other race/ethnicity, and 79% White participants. The most common psychiatric diagnosis was attention-deficit/hyperactivity disorder (91.6%). The majority of first prescriptions of psychotropic medications were written by primary care physicians or pediatricians (69%) rather than psychiatrists. Recommendations were not affected by patient socioeconomic status, race/ethnicity, or insurance (all Conclusion: Children's socioeconomic status, race/ethnicity, and insurance did not affect treatment recommendations of clinicians. However, children whose first prescription of psychotropic medication was from a primary care physician or pediatrician were less likely to have a recommendation for psychotherapy compared with children who were seen by psychiatrists. Diversity & Inclusion Statement: One or more of the authors of this paper self-identifies as a member of one or more historically underrepresented racial and/or ethnic groups in science. One or more of the authors of this paper self-identifies as a member of one or more historically underrepresented sexual and/or gender groups in science. We actively worked to promote sex and gender balance in our author group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.